» Articles » PMID: 25325058

Diabetes Mellitus and Electrolyte Disorders

Overview
Specialty General Medicine
Date 2014 Oct 18
PMID 25325058
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic patients frequently develop a constellation of electrolyte disorders. These disturbances are particularly common in decompensated diabetics, especially in the context of diabetic ketoacidosis or nonketotic hyperglycemic hyperosmolar syndrome. These patients are markedly potassium-, magnesium- and phosphate-depleted. Diabetes mellitus (DM) is linked to both hypo- and hyper-natremia reflecting the coexistence of hyperglycemia-related mechanisms, which tend to change serum sodium to opposite directions. The most important causal factor of chronic hyperkalemia in diabetic individuals is the syndrome of hyporeninemic hypoaldosteronism. Impaired renal function, potassium-sparing drugs, hypertonicity and insulin deficiency are also involved in the development of hyperkalemia. This article provides an overview of the electrolyte disturbances occurring in DM and describes the underlying mechanisms. This insight should pave the way for pathophysiology-directed therapy, thus contributing to the avoidance of the several deleterious effects associated with electrolyte disorders and their treatment.

Citing Articles

Rodent Models of Diabetic Neuropathy, Role of Calcium Homeostasis in Pain and KB-R7943 as a Potential Therapeutic.

Ivanova N, Hristov M, Gateva P Int J Mol Sci. 2025; 26(5).

PMID: 40076715 PMC: 11899846. DOI: 10.3390/ijms26052094.


Integrated analysis of long non‑coding RNA megacluster, microRNA‑132 and microRNA‑133a and their implications for cardiovascular risk and kidney failure progression in diabetic patients.

AbdElgayed G, Hosni A, Abdel-Moneim A, Malik A, Zaky M, Hasona N Exp Ther Med. 2025; 29(2):35.

PMID: 39776891 PMC: 11705225. DOI: 10.3892/etm.2024.12785.


Major electrolyte disorder and associated factors among patients with chronic disease in Ethiopia: a systematic review and meta-analysis.

Tassew W, Ferede Y, Zeleke A BMC Nephrol. 2024; 25(1):435.

PMID: 39614197 PMC: 11606226. DOI: 10.1186/s12882-024-03873-8.


Hyponatremia Associated with the Use of Common Antidepressants in the All of Us Research Program.

Mo H, Channa Y, Ferrara T, Waxse B, Schlueter D, Tran T Clin Pharmacol Ther. 2024; 117(2):534-543.

PMID: 39540435 PMC: 11739749. DOI: 10.1002/cpt.3484.


Acute and sub-acute toxicity study of aqueous and methanol root extract of in male albino rats.

Ainyanbhor I, Onoagbe I, Edo G, Yousif E, Akpoghelie P, Owheruo J Toxicol Rep. 2024; 13:101786.

PMID: 39526239 PMC: 11543917. DOI: 10.1016/j.toxrep.2024.101786.


References
1.
Balint E, Szabo P, Marshall C, Sprague S . Glucose-induced inhibition of in vitro bone mineralization. Bone. 2001; 28(1):21-8. DOI: 10.1016/s8756-3282(00)00426-9. View

2.
BAUZA J, Ortiz J, Dahan M, Justiniano M, Saenz R, Velez M . Reliability of serum magnesium values during diabetic ketoacidosis in children. Bol Asoc Med P R. 1999; 90(7-12):108-12. View

3.
Wilson H, Keuer S, Lea A, Boyd 3rd A, Eknoyan G . Phosphate therapy in diabetic ketoacidosis. Arch Intern Med. 1982; 142(3):517-20. View

4.
Moe S . Disorders involving calcium, phosphorus, and magnesium. Prim Care. 2008; 35(2):215-37, v-vi. PMC: 2486454. DOI: 10.1016/j.pop.2008.01.007. View

5.
Paolisso G, Sgambato S, Passariello N, Giugliano D, Scheen A, DOnofrio F . Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia. 1986; 29(9):644-7. DOI: 10.1007/BF00869264. View